Competition ABM/2022/6
The Medical Research Agency has published the Regulations for the Competition dedicated to the entrepreneurs: for the development of targeted or personalised medicine based on nucleic acid and small molecule compounds (ABM/2022/6). If you collaborate with the private sector entities which conduct activities defined within the Competition frames, you are encouraged to contact the Clinical […]